Alpha-2-macroglobulin messenger RNA 3'-untranslated region (A2M mRNA 3'-UTR) (A2M mRNA 3'-UTR)

The Alpha-2-macroglobulin (A2M) mRNA 3'-untranslated region (3'-UTR) is a regulatory sequence located at the 3' end of the A2M messenger RNA, following the stop codon (NCBI Gene ID: 2). This region plays a pivotal role in the post-transcriptional control of A2M expression by serving as a scaffold for microRNAs (miRNAs) and RNA-binding proteins that dictate mRNA decay and translation rates (UniProt P01023). A2M itself is a massive plasma glycoprotein that functions as a universal protease inhibitor, neutralizing enzymes like collagenases and inflammatory cytokines that contribute to tissue degradation. In the context of osteoarthritis, the 3'-UTR is a focal point for research into therapies that could prevent the downregulation of A2M, thereby protecting joint cartilage from catabolic enzymes like ADAMTS-4 and ADAMTS-5 (Wang et al., 2014, PMID: 25163445). Furthermore, genetic variations within the A2M 3'-UTR have been investigated for their association with Alzheimer's disease risk, as A2M facilitates the clearance of amyloid-beta plaques (Kovacs, 2000, PMID: 11092115). Although no small molecules or biologics currently target this UTR in the clinic, it is a candidate for antisense oligonucleotide (ASO) technology and miRNA-based interventions designed to fine-tune A2M levels in degenerative and inflammatory disorders. These RNA-targeted approaches aim to exploit the regulatory motifs within the 3'-UTR to either stabilize the transcript or enhance its translation, offering a novel pathway for treating chronic proteolytic diseases.

Other names

A2M 3'-UTRAlpha-2-macroglobulin 3'-untranslated regionCPAMD1 3'-UTRAlpha-2-M 3'-UTR

Modulation of protein expression by altering mRNA stability or translation efficiency through sequence-specific binding to regulatory motifs.